| Ticker Details |
Pacira BioSciences, Inc.
Pacira Pharmaceuticals Inc is a specialty and generic drug manufacturing company. The company develops, manufactures, and commercializes pharmaceutical products for use in hospitals and ambulatory surgery centers across the United States.
|
| IPO Date: |
February 3, 2011 |
| Sector: |
Healthcare |
| Industry: |
Drug Manufacturers |
| Market Cap: |
$983.39M |
| Activated in VL: |
True |
| Average Daily Range |
| Avg Daily Range: |
$0.88 | 2.38%
|
| Avg Daily Range (30 D): |
$0.47 | 1.83%
|
| Avg Daily Range (90 D): |
$0.47 | 1.93%
|
| Institutional Daily Volume |
| Avg Daily Volume: |
.52M |
| Avg Daily Volume (30 D): |
.47M |
| Avg Daily Volume (90 D): |
.39M |
| Trade Size |
| Avg Trade Size (Sh.): |
82 |
| Avg Trade Size (Sh.) (30 D): |
49 |
| Avg Trade Size (Sh.) (90 D): |
48 |
| Institutional Trades |
| Total Institutional Trades: |
9,174 |
| Avg Institutional Trade: |
$1.79M |
| Avg Institutional Trade (30 D): |
$2.46M |
| Avg Institutional Trade (90 D): |
$1.97M |
| Avg Institutional Trade Volume: |
.04M |
| Avg Institutional Trades (Per Day): |
2 |
| Market Closing Trades |
| Avg Closing Trade: |
$2.37M |
| Avg Closing Trade (30 D): |
$2.78M |
| Avg Closing Trade (90 D): |
$2.64M |
| Avg Closing Volume: |
63.89K |
|
|
| Financials |
| |
TTM |
Q2 2026 |
Q1 2026 |
|
Basic EPS
|
$.35
|
$.12
|
$.07
|
|
Diluted EPS
|
$.35
|
$.12
|
$.07
|
|
Revenue
|
$746.16M
|
$192.4M
|
$177.38M
|
|
Gross Profit
|
$591.01M
|
$148.24M
|
$140.96M
|
|
Net Income / Loss
|
$14.64M
|
$4.65M
|
$2.92M
|
|
Operating Income / Loss
|
$19.87M
|
$4.27M
|
$6.9M
|
|
Cost of Revenue
|
$155.15M
|
$44.16M
|
$36.41M
|
|
Net Cash Flow
|
$-94.61M
|
|
|
|
PE Ratio
|
|
|
|
|
|
|
